1st Counsel – Lifestyle
Author:
Damora Therapeutics, Inc.
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 30, 2026
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
March 23, 2026
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
March 19, 2026